Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/1994
02/23/1994EP0583699A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments
02/23/1994EP0583698A2 Deoxycyclitol derivatives, process for their preparation and their use in medicaments
02/23/1994EP0583606A2 New hydrazono-5-beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
02/23/1994EP0583579A2 New 17-hydroxyiminomethyl-5beta, 14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
02/23/1994EP0583578A2 17-(3-Furyl) and 17-(4-pyridazinyl)-5beta,14beta-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
02/23/1994EP0583421A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
02/23/1994EP0583408A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
02/23/1994EP0583360A1 Compositions for the prevention and/or treatment of pathological processes
02/23/1994EP0583346A1 Bicyclic amides as inhibitors of acyl-coenzyme a: cholesterol acyl transferase
02/23/1994EP0583322A1 Antiserotonines, prepartion thereof and medicaments containing them
02/23/1994EP0461111B1 Treatment of osteoporosis
02/23/1994CN1082545A Imidazopyridine
02/23/1994CN1082543A 吲哚衍生物 Indole derivatives
02/23/1994CN1082542A 苯并咪唑衍生物 Benzimidazole derivatives
02/23/1994CN1082538A Imidazolyl-substituted cyclohexane derivatives
02/22/1994US5288757 Aminosulfonyl urea ACAT inhibitors and a method of lowering blood cholesterol levels therewith
02/22/1994US5288751 [(Substituted) phenyalkyl]furylalkynyl-and [substituted) phenyalkyl] thienylalkynyl-N-hydroxyurea inhibitors or leukotriene biosynthesis
02/22/1994US5288749 Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors
02/22/1994US5288733 Leukotriene synthesis inhibitors
02/22/1994US5288724 Antiserotonine agents, hypotensive agents, antidepressants
02/22/1994US5288717 Alkali metal salt of 8,9-dehydroestrone intermediate
02/21/1994CA2103824A1 Hydrazono-5.beta., 14.beta.-androstane derivatives active on the car diovascular system, processes for their preparation and pharmaceutical compositions containing same
02/19/1994CA2104051A1 Deoxymyoinositol derivatives, process for their preparation and their use in medicaments
02/19/1994CA2104049A1 Substituted derivatives of deoxymyoinositol, process for their preparation and their use in medicaments
02/18/1994CA2103644A1 Method for preventing and treating atherosclerosis
02/17/1994WO1994003481A1 Diamino acid derivatives as antihypertensives
02/17/1994WO1994003479A1 Thrombin receptor antagonists
02/17/1994WO1994003469A1 New derivatives of neuraminic acid
02/17/1994WO1994003456A1 Asymmetrically substituted xanthine with adenosine-antagonistic properties
02/17/1994WO1994003444A1 Amide derivatives
02/17/1994WO1994003435A1 Prodrugs of imidazole carboxylic acids as angiotensin ii receptor antagonists
02/17/1994WO1994003431A1 Isoserine derivatives and their use as leukotriene antagonists
02/17/1994WO1994003427A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
02/17/1994WO1994003421A2 Esters and combinations of an organic nitrate and a salicylate
02/17/1994WO1994003178A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine
02/17/1994WO1994003171A1 Cardiac protective
02/17/1994WO1994000555A3 Compositions for the inhibition of protein hormone formation and uses thereof
02/17/1994WO1993025577A3 Active component of parathyroid hypertensive factor
02/17/1994WO1993020839A3 Use of renin-angiotensin antagonist for reducing post myocardial infarct mobidity and mortality
02/17/1994CA2141810A1 Amide derivatives
02/17/1994CA2141785A1 Diamino acid derivatives as antihypertensives
02/17/1994CA2141557A1 Therapeutic use of phosphoryl-l-serine-n-acyl-sphingosine
02/17/1994CA2141435A1 Ester of an organic nitrate and a salicylate
02/17/1994CA2140883A1 Asymmetrically substituted xanthines
02/17/1994CA2140440A1 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
02/17/1994CA2134565A1 Isoserine derivatives and their use as leukotriene antagonists
02/16/1994EP0583074A2 Angiotensin converting enzyme inhibitor and method for preparing same
02/16/1994EP0582916A1 N-methansulfonyl-2-(3-isobutyl-3-(quinol-2-yl-methoxy)-phenyl)-2-cycloalkylacetamides, process for their preparation and their pharmaceutical use
02/16/1994EP0343241B1 A method of inhibiting platelet dependent arterial thrombosis
02/16/1994CN1082045A Imidazopyridines
02/16/1994CN1082044A 吲哚衍生物 Indole derivatives
02/16/1994CN1082043A Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
02/16/1994CN1082042A Diazabicycloalkene derivatives
02/16/1994CN1082029A Biphenylmethyl-substituted pyridones
02/16/1994CN1082027A 异羟肟酸衍生物 Hydroxamic acid derivatives
02/16/1994CN1081890A Prescription and production method of medicine to cure stenocardia-type coronary heart disease
02/16/1994CN1023800C Improvements in pharmaceutically acceptable salts
02/15/1994US5286858 Optically active thienotriazolodiazepine compounds
02/15/1994US5286735 Derivatives of 4-aminomethylpiperidine, their preparation and their use as therapeutics
02/15/1994US5286718 Administering monophosphoryl lipid A or its 3-deacylated derivative
02/15/1994US5286716 Inhibitor of the proliferation of endothelial cells
02/15/1994US5286487 Covalent angiogenin/RNase hybrids
02/15/1994US5286252 Diagnosis, evaluation and treatment of coronary artery disease by exercise simulation using closed loop drug delivery of an exercise simulating agent beta agonist
02/15/1994CA1327006C Process for preparing a retard product containing diltiazem for a single daily administration
02/15/1994CA1327004C Stabilized pharmaceutical composition and method of producing same
02/13/1994CA2103600A1 Isobutyl-substituted methanesulphonyl- quinolyl-methoxyphenyl-cycloalkylacetamides
02/12/1994CA2103601A1 1,4-benzodioxane derivatives
02/09/1994EP0582506A1 Tetrahydronaphtalene derivatives, their preparation and their application in therapy
02/09/1994EP0582330A1 Use of polysaccharides for treating acute peripheral neuropathies
02/09/1994EP0582164A1 Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
02/09/1994EP0582146A2 Process for the preparation of imidazopyridines
02/09/1994EP0581979A1 Quinic acid derivatives and process to prepare quinic acid derivatives
02/09/1994EP0581939A1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors
02/09/1994EP0581899A1 Improved process for the preparation of 1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n- (1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide
02/09/1994EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage
02/09/1994EP0581797A1 Novel thiophene-2-carboxylic acid derivatives and process for their production.
02/09/1994EP0581777A1 Stereoselective preparation of substituted piperidines
02/09/1994CN1081682A 甾类衍生物 Steroid derivatives
02/09/1994CN1081678A Pyridino-, pyrrolidino- and azepino-substituted oximes useful as anti-atherosclerosis and anti-hypercholesterolemic agents
02/09/1994CN1023702C Process for preparing imidazole derivative
02/08/1994US5284957 Substituted 1H- or 2H-tetrazoles
02/08/1994US5284868 Naphthopyran derivatives; for autoimmune diseases, cancer
02/08/1994US5284857 Substituted thienopyrans as antihypertensive agents
02/08/1994US5284849 Renin inhibitors
02/08/1994US5284839 Neuropeptide antagonist; renal and cerebral areas included
02/08/1994US5284827 Systemic treatment of metastatic cancer with platelet factor 4
02/08/1994US5284755 DNA encoding leukemia inhibitory factor receptors
02/08/1994CA1326851C Oxadiazolyl-1,4-dihydropyridines and the analogues thereof
02/06/1994CA2101915A1 Tetrahydronaphthalene derivatives, their preparation and their application in therapy
02/06/1994CA2101789A1 Process for the preparation of imidazopyridines
02/04/1994CA2101230A1 Derivatives of quinic acid and a process for their production
02/03/1994WO1994002595A1 Method and reagent for treatment of animal diseases
02/03/1994WO1994002511A1 Calcium channel blocking polypeptide from agelenopsis aperta
02/03/1994WO1994002498A1 Hybrid oligonucleotide phosphorothioates
02/03/1994WO1994002493A1 Phosphonated arylethanolamine compounds with anti-hyperglycemic and/or anti-obesity activity
02/03/1994WO1994002488A1 BIS-STAUROSPORINE AND K-252a DERIVATIVES
02/03/1994WO1994002474A1 Endothelin receptor antagonists
02/03/1994WO1994002473A1 N-cycloalkylpiperazine derivatives, methods of obtaining them and pharmaceutical compositions containing them
02/03/1994WO1994002463A1 Antihypertensive 1,4-dihydropyridine derivatives and process for their preparation
02/03/1994WO1994002453A1 Ng-monomethyl-l-arginine hydrochloride derivatives and their use in the treatment of septic shock